Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oluwatomi Ibidapo-Obe

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
JHEP Reports : Innovation in Hepatology|September 11, 2023
Tissue-resident and innate-like T cells in patients with advanced chronic liver diseaseOluwatomi Ibidapo-Obe, Tony Bruns
Expert Review of Clinical Immunology|September 29, 2025
Peritoneal immunity in decompensated cirrhosisOluwatomi Ibidapo-Obe, Michael D Rooney, Tony Bruns
Cellular and Molecular Gastroenterology and Hepatology|January 19, 2020
Mucosal-Associated Invariant T Cells Redistribute to the Peritoneal Cavity During Spontaneous Bacterial Peritonitis and Contribute to Peritoneal InflammationOluwatomi Ibidapo-Obe, Sven Stengel, Nilay Köse-Vogel, et al.
Scientific Reports|July 16, 2025
The prognostic significance of HDL-associated apolipoproteins in ascitic fluid from patients with cirrhosis and spontaneous bacterial peritonitisMohamad Murad, Philipp A Reuken, Kristin Schubert, et al.
Journal of Intensive Care|June 11, 2022
Soluble mannose receptor CD206 and von Willebrand factor are early biomarkers to identify patients at risk for severe or necrotizing acute pancreatitisPhilipp A Reuken, Jonathan F Brozat, Stefanie Quickert, et al.
Gastroenterology|January 27, 2020
Peritoneal Level of CD206 Associates With Mortality and an Inflammatory Macrophage Phenotype in Patients With Decompensated Cirrhosis and Spontaneous Bacterial PeritonitisSven Stengel, Stefanie Quickert, Philipp Lutz, et al.
JHEP Reports : Innovation in Hepatology|December 17, 2021
Immunomodulatory receptor VSIG4 is released during spontaneous bacterial peritonitis and predicts short-term mortalityJohanna Reißing, Philipp Lutz, Mick Frissen, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
JHEP Reports : Innovation in Hepatology|September 11, 2023
Tissue-resident and innate-like T cells in patients with advanced chronic liver diseaseOluwatomi Ibidapo-Obe, Tony Bruns
Expert Review of Clinical Immunology|September 29, 2025
Peritoneal immunity in decompensated cirrhosisOluwatomi Ibidapo-Obe, Michael D Rooney, Tony Bruns
Cellular and Molecular Gastroenterology and Hepatology|January 19, 2020
Mucosal-Associated Invariant T Cells Redistribute to the Peritoneal Cavity During Spontaneous Bacterial Peritonitis and Contribute to Peritoneal InflammationOluwatomi Ibidapo-Obe, Sven Stengel, Nilay Köse-Vogel, et al.
Scientific Reports|July 16, 2025
The prognostic significance of HDL-associated apolipoproteins in ascitic fluid from patients with cirrhosis and spontaneous bacterial peritonitisMohamad Murad, Philipp A Reuken, Kristin Schubert, et al.
Journal of Intensive Care|June 11, 2022
Soluble mannose receptor CD206 and von Willebrand factor are early biomarkers to identify patients at risk for severe or necrotizing acute pancreatitisPhilipp A Reuken, Jonathan F Brozat, Stefanie Quickert, et al.
Gastroenterology|January 27, 2020
Peritoneal Level of CD206 Associates With Mortality and an Inflammatory Macrophage Phenotype in Patients With Decompensated Cirrhosis and Spontaneous Bacterial PeritonitisSven Stengel, Stefanie Quickert, Philipp Lutz, et al.
JHEP Reports : Innovation in Hepatology|December 17, 2021
Immunomodulatory receptor VSIG4 is released during spontaneous bacterial peritonitis and predicts short-term mortalityJohanna Reißing, Philipp Lutz, Mick Frissen, et al.
Pageof 1